The Washington Post By: Lenny Bernstein Health officials scrambled Friday to explain President Trump’s plan to send $200 prescription drug discount cards to 33 million Medicare recipients as experts cast doubt on the proposal and Democrats accused the president of blatant political chicanery less than six weeks before the election… With little information to go […]
Kaiser Health News By: Angela Hart and Samantha Young California is poised to become the first state to develop its own line of generic drugs, targeting soaring drug prices and stepping into a fiercely competitive drug market dominated by deep-pocketed pharmaceutical companies… “Other legislative efforts in Congress and in other states have focused on government […]
CCF has submitted public comments to the Centers for Medicare and Medicaid Services (CMS) on the proposed Medicaid drug rebate rule which, among other things, would change how drug manufacturers report “best price” under the effective Medicaid Drug Rebate Program. As I have explained, the proposed rule’s best price reporting changes are intended to facilitate […]
Vox By: Dylan Scott Remdesivir, the antiviral drug that appears to reduce the recovery time for hospitalized Covid-19 patients, has a price tag: $3,120 for the typical five-day regiment for a patient on private insurance. Gilead, the drug’s manufacturer, announced the news on Monday…. Edwin Park at the Georgetown Center on Children and Families told […]
On September 29, the President signed into law a fiscal year 2020 appropriations bill (H.R. 4378) that temporarily funds the federal government through November 21. The bill also includes several short-term extensions of critical health provisions that were scheduled to expire: full Medicaid funding for Puerto Rico and the other territories, a delay in scheduled […]
Editor’s Note: The Senate Finance Committee reported the bill on July 25, 2019 (without substantive changes to its Medicaid provisions.) On Thursday, July 25, the Senate Finance Committee is scheduled to consider bipartisan drug pricing legislation (known as the Prescription Drug Pricing Reduction Act). While much of the bill focuses on provisions related to Medicare […]
